{
  "ptid_time": "033_S_0920_2012-10-05",
  "img_path": "/data/qiuhui/data/adni/images/033_S_0920/2012-10-05/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 55,291 mm³, 49.6% above the reference mean. With a Z-score of 1.34 (91.0th percentile), this represents mild enlargement; hippocampal volume measures 4,691 mm³, 27.8% below the reference mean. With a Z-score of -2.23 (1.3th percentile), this represents significant atrophy; whole brain volume measures 845,113 mm³, 8.9% below the reference mean. With a Z-score of -1.07 (14.1th percentile), this represents mild atrophy; entorhinal cortex volume measures 2,283 mm³, 34.1% below the reference mean. With a Z-score of -1.84 (3.3th percentile), this represents moderate atrophy; fusiform gyrus volume measures 15,505 mm³, 3.8% below the reference mean. With a Z-score of -0.28 (38.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,826 mm³, 12.2% below the reference mean. With a Z-score of -1.09 (13.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 86.0 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 30.0. MoCA: 21.0. Logical Memory: 6.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.16 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal atrophy (Z-score -2.23, 1.3th percentile) and moderate entorhinal cortex atrophy (Z-score -1.84, 3.3th percentile), both strongly associated with Alzheimer's pathology. The MoCA score of 21 suggests cognitive impairment, while the MMSE of 30 is unexpectedly normal, possibly due to test insensitivity or practice effects. The presence of one APOE4 allele increases Alzheimer's risk, but the normal AV45 (amyloid PET) is discordant with the structural findings.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype given hippocampal involvement)  \n**Confidence:** **Medium** (due to the discrepancy between MMSE/MoCA and the unclear amyloid status despite high-risk imaging features)  \n\n*Note: A follow-up clinical evaluation focusing on episodic memory and repeat cognitive testing would help clarify progression. The normal AV45 may warrant further investigation (e.g., CSF biomarkers or tau PET) to reconcile the discordance with structural atrophy.*",
  "timestamp": "2025-07-26T05:23:13.422711"
}